Search research articles
Contact Us
Filters
Showing results (111-120 of 146) with videos related to
Page
of 15
Sort By:
Journal of Pediatric Hematology/Oncology
|
February 28, 2022
Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia
Rikke L Nielsen, Benjamin O Wolthers, Marianne Helenius, et al.
EMBO Molecular Medicine
|
November 4, 2018
PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia
Paulina Richter-Pechańska, Joachim B Kunz, Beat Bornhauser, et al.
Hemasphere
|
September 4, 2025
Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapy
Gunnar Cario, Maria Grazia Valsecchi, Valentino Conter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 3, 2017
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome
Omer Schwartzman, Angela Maria Savino, Michael Gombert, et al.
Nature Immunology
|
May 2, 2017
S100-alarmin-induced innate immune programming protects newborn infants from sepsis
Thomas Ulas, Sabine Pirr, Beate Fehlhaber, et al.
Blood
|
February 19, 2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000
Anja Möricke, Martin Zimmermann, Maria Grazia Valsecchi, et al.
Leukemia
|
May 18, 2022
Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution
Paulina Richter-Pechańska, Joachim B Kunz, Tobias Rausch, et al.
Blood
|
February 16, 2010
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter, Claus R Bartram, Maria Grazia Valsecchi, et al.
EMBO Molecular Medicine
|
August 6, 2020
Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors
Büşra Erarslan-Uysal, Joachim B Kunz, Tobias Rausch, et al.
Blood Advances
|
April 10, 2024
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
Gaia Gentile, Teresa Poggio, Antonella Catalano, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 146) with videos related to
Sort By:
Page
of 15
Journal of Pediatric Hematology/Oncology
|
February 28, 2022
Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia
Rikke L Nielsen, Benjamin O Wolthers, Marianne Helenius, et al.
EMBO Molecular Medicine
|
November 4, 2018
PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia
Paulina Richter-Pechańska, Joachim B Kunz, Beat Bornhauser, et al.
Hemasphere
|
September 4, 2025
Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapy
Gunnar Cario, Maria Grazia Valsecchi, Valentino Conter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 3, 2017
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome
Omer Schwartzman, Angela Maria Savino, Michael Gombert, et al.
Nature Immunology
|
May 2, 2017
S100-alarmin-induced innate immune programming protects newborn infants from sepsis
Thomas Ulas, Sabine Pirr, Beate Fehlhaber, et al.
Blood
|
February 19, 2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000
Anja Möricke, Martin Zimmermann, Maria Grazia Valsecchi, et al.
Leukemia
|
May 18, 2022
Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution
Paulina Richter-Pechańska, Joachim B Kunz, Tobias Rausch, et al.
Blood
|
February 16, 2010
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter, Claus R Bartram, Maria Grazia Valsecchi, et al.
EMBO Molecular Medicine
|
August 6, 2020
Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors
Büşra Erarslan-Uysal, Joachim B Kunz, Tobias Rausch, et al.
Blood Advances
|
April 10, 2024
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
Gaia Gentile, Teresa Poggio, Antonella Catalano, et al.
Page
of 15